☰

David Blum

Affiliations: 
Clinical Research & Medical Affairs Biodelivery Sciences International, Raleigh, NC, United States 
Area:
drug development, pain, other areas
Google:
"David Blum"
Bio:

Biodelivery Sciences International - 2007 -
GlaxoSmithKline 2001-2007
Barrow Neurological Institute 1991-2001
UCLA Medical Center - Neuropsychiatric Institute
...fellowship 1989-1991
...residency 1986-1989
Medical College of Pennsylvania 1985-1986
UCSD School of Medicine 1981-1985
UCLA Biology 1979-1981
Caltech 1973-1977

Mean distance: 14.89 (cluster 31)
 		SNBCP
Tree Publications Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

Parents

Sign in to add mentor
Jerome Engel Jr post-doc 1989-1991 UCLA
Marc R. Nuwer post-doc 1989-1991 UCLA

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mintzer S, Constantino T, Gidal B, et al. (2019) Markers of bone and lipid metabolism with eslicarbazepine acetate monotherapy. Epilepsy Research. 158: 106216
Chung S, Sinha SR, Shah A, et al. (2019) Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures. Epilepsy Research. 153: 59-65
Abou-Khalil B, Klein P, Shah A, et al. (2018) Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures. Epilepsy Research. 147: 80-86
Mintzer S, Wechsler RT, Rogin JB, et al. (2018) Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs. Epilepsy Research. 141: 83-89
Pazdera L, Sperling MR, Harvey JH, et al. (2018) Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine. Epilepsia
Gidal BE, Mintzer S, Schwab M, et al. (2017) Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters. Epilepsy Research. 135: 64-70
French JA, Mintzer S, Perucca E, et al. (2016) Reflections on monotherapy trials for epilepsy - Authors' reply. The Lancet. Neurology. 15: 657-8
Sperling MR, French J, Jacobson MP, et al. (2016) Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies. Neurology
Mintzer S, French JA, Perucca E, et al. (2015) Is a separate monotherapy indication warranted for antiepileptic drugs? The Lancet. Neurology. 14: 1229-40
Sperling MR, Harvey J, Grinnell T, et al. (2015) Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North America. Epilepsia. 56: 546-55
See more...